Search Results - "Dorsey, F C"

Metabolic Messengers: itaconate by McGettrick, A. F., Bourner, L. A., Dorsey, F. C., O’Neill, L. A. J.

“…The metabolite itaconate has emerged as an important immunoregulator with roles in antibacterial defence, inhibition of inflammation and, more recently, as an…”
Get full text

GM-1 ganglioside in human spinal cord injury by Geisler, F H, Dorsey, F C, Coleman, W P

“…Spinal cord injury is typically a devastating injury with no or only limited neurologic recovery. Recent papers have reported enhancement of neurologic…”
Get more information

Past and current clinical studies with GM-1 ganglioside in acute spinal cord injury by Geisler, F H, Dorsey, F C, Coleman, W P

“…Two recent prospective, randomized, placebo-controlled, double-blinded clinical drug studies in acute spinal cord injury have reported enhancement of…”
Get more information

Recovery of Motor Function after Spinal-Cord Injury — A Randomized, Placebo-Controlled Trial with GM-1 Ganglioside by Geisler, Fred H, Dorsey, Frank C, Coleman, William P

“…THE modern treatment of patients with spinal-cord injuries began during World War II in England, and its success led to the development of centers treating…”
Get full text

Chagas' cardioneuropathy: effect of ganglioside treatment in chronic dysautonomic patients--a randomized, double-blind, parallel, placebo-controlled study by Iosa, D, Massari, D C, Dorsey, F C

“…To date, there is no effective pharmacologic treatment for Chagas' cardioneuropathy, one of the most common causes of congestive heart failure and sudden death…”
Get more information

Refining the treatment of women with unstable angina--a randomized, double-blind, comparative safety and efficacy evaluation of Integrelin versus aspirin in the management of unstable angina by Goldschmidt-Clermont, P J, Schulman, S P, Bray, P F, Chandra, N C, Grigoryev, D, Dise, K R, Sagar, M, Fox, R J, Coleman, L D, Richardson, C, Dorsey, F C, du Mee, C, Kitt, M M, Ouyang, P, Baughman, K L, Gerstenblith, G

“…Although women typically develop coronary artery disease several years after men, once they have symptomatic disease their thromboembolic complications are…”
Get more information

GM-1 ganglioside in human spinal cord injury by Geisler, F H, Dorsey, F C, Coleman, W P

“…Spinal cord injury is typically a devastating injury with no or only limited neurologic recovery. Recent papers have reported enhancement of neurologic…”
Get more information

The Effect of Aging on Human Serum Immunoglobulin Concentrations by Buckley, C. E., III, Dorsey, F. C

“…Single radial diffusion was used to measure the concentration of IgG, IgA and IgM in sera of 811 healthy individuals aged from birth to 92 years. Evaluation of…”
Get full text

GM1 gangliosides in the treatment of spinal cord injury: report of preliminary data analysis by Geisler, F H, Dorsey, F C, Coleman, W P

“…A prospective, randomized, placebo-controlled, double-blinded spinal cord injury GM1 ganglioside drug trial was completed. Of the 37 patients entered over a 16…”
Get full text

Serum immunoglobulin levels throughout the life-span of healthy man by Buckley, 3rd, C E, Dorsey, F C

Get more information

HL-A-Linked Human Immune-Response Genes by Buckley, C. E., Dorsey, F. C., Corley, R. B., Ralph, W. B., Woodbury, M. A., Amos, D. B.

“…Genetic control of the response to specific natural-product antigens has been documented in three informative families. Families were selected on the basis of…”
Get full text

Cerebral arterial spasm--a controlled trial of nimodipine in patients with subarachnoid hemorrhage by Allen, G S, Ahn, H S, Preziosi, T J, Battye, R, Boone, S C, Chou, S N, Kelly, D L, Weir, B K, Crabbe, R A, Lavik, P J, Rosenbloom, S B, Dorsey, F C, Ingram, C R, Mellits, D E, Bertsch, L A, Boisvert, D P, Hundley, M B, Johnson, R K, Strom, J A, Transou, C R

“…We enrolled 125 neurologically normal patients with intracranial aneurysms in a multi-institution, prospective, double-blind, randomized, placebo-controlled…”
Get more information

A comparison of serum immunoglobulin concentrations in sarcoidosis and tuberculosis by Buckley, 3rd, C E, Dorsey, F C

Get more information

Design and baseline results of the monosialoganglioside early stroke trial by ROCCA, W. A, DORSEY, F. C, FIESCHI, C, GRIGOLETTO, F, GENT, M, ROBERTS, R. S, WALKER, M. D, EASTON, J. D, BRUNO, R, CAROLEI, A, SANCESARIO, G

Get full text

Longitudinal changes in serum immunoglobulin levels in older humans by Buckley, 3rd, C E, Buckley, E G, Dorsey, F C

Get more information

Age-dependent immunophysiologic correlates of chronic respiratory disease by Buckley, 3rd, C E, Dorsey, F C, Sieker, H O

Get more information

Design and baseline results of the monosialoganglioside early stroke trial. The EST Study Group by Rocca, W A, Dorsey, F C, Grigoletto, F, Gent, M, Roberts, R S, Walker, M D, Easton, J D, Bruno, R, Carolei, A, Sancesario, G

“…The Early Stroke Trial is a randomized, placebo-controlled, double-masked, multicenter study to assess the safety and efficacy of monosialoganglioside in…”
Get full text

Addendum: immunoglobulins and ethnic groups by Buckley, C E, Dorsey, F C

Get more information

Ganglioside administration in retinitis pigmentosa by Newsome, D A, Dorsey, F C, May, J G, Bergsma, D R, Bazan, N G

“…The retinitis pigmentosa process typically causes variably progressive visual loss due to retinal photoreceptor and pigment epithelial cell deterioration. No…”
Get more information

Early treatment of stroke with monosialoganglioside GM-1 : efficacy and safety results of the early stroke trial by LENZI, G. L, GRIGOLETTO, F, PATARNELLO, F, FIESCHI, C, GENT, M, ROBERTS, R. S, WALKER, M. D, EASTON, J. D, CAROLEI, A, DORSEY, F. C, ROCCA, W. A, BRUNO, R

“…The Early Stroke Trial (EST) is a randomized, double-blind, placebo-controlled trial to assess the effect of monosialoganglioside GM-1 in improving recovery in…”
Get full text